Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
ABSTRACT Disclosure of potential conflicts of interest (COI) is used by biomedical journals to guarantee credibility and transparency of the scientific process. COI disclosure, however, is not systematically nor consistently dealt with by journals. Recent joint editorial efforts paved the way towards the implementation of uniform vehicles for COI disclosure. This paper provides a comprehensive editorial perspective on classical COI-related issues. New insights into current COI policies and practices among European Society of Cardiology national cardiovascular journals, as derived from a cross-sectional survey using a standardised questionnaire, are discussed.
SourceAvailable from: Véronique Delpire[Show abstract] [Hide abstract]
ABSTRACT: Evolving standards of good publication practice (GPP) and a survey conducted in 2009 of authors, who were investigators and researchers not employed by the company prompted changes to GSK Vaccines' publication practices. We conducted a follow-up survey in 2012 to assess the company's revised practices and to evaluate understanding of GPP among investigators and researchers who had previously authored at least one publication in collaboration with GSK Vaccines. The 50-question web-based survey addressed authoring practices and transparency of decision-making. Investigators and researchers (n = 1,273) who had authored at least one publication reporting on GSK Vaccines-sponsored human research since 2007, were invited to participate. Responses to 37 closed questions are presented. The remaining 13 questions were open-ended or did not concern publication practices. A total of 415 external authors (32.6%) responded. International Committee of Medical Journal Editors (ICMJE) authorship criteria were clear to most respondents (78.1%); 7.7% found they were unclear. The majority of participants (86.8%) found GSK Vaccines' authorship questionnaire a suitable tool to assess eligibility for authorship as per the ICMJE criteria. However, only 68.5% felt that the outcome of the questionnaire is communicated appropriately and 58.3% felt well informed on changes in authorship. Nearly two-thirds (62.9%) of respondents felt that having a pharmaceutical company employee as lead author makes manuscript acceptance less likely. Access to relevant data was regarded as sufficient by 78.5% of respondents. Briefing meetings before publication start, publication steering committees and core writing teams were recognized as valuable publication practices. Professional medical writing support was seen as adding value to publication development by 87.7% of participants. Most respondents agreed that manuscript discussions should start early, with 81.7% stating that they were in favor of introducing a formalized 'author agreement' at the publication start. GSK Vaccines made changes to its publication practices to ensure improved transparency and better involvement of external authors. The results of this survey suggest that these changes have been effective to a large extent. They confirm the need for effective and timely communication, as well as transparent processes for authorship and decision-making during publication development. The identified gaps in GPP will help to guide further improvements to the company's policies on publication practices.Trials 11/2014; 15(1):446. DOI:10.1186/1745-6215-15-446 · 2.12 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: European Society of Cardiology (ESC) National Society Cardiovascular Journals (NSCJs) are high-quality biomedical journals focused on cardiovascular diseases. The Editors´ Network of the ESC devises editorial initiatives aimed at improving the scientific quality and diffusion of NSCJ. In this article we will discuss on the importance of the Internet, electronic editions and open access strategies on scientific publishing. Finally, we will propose a new editorial initiative based on a novel electronic tool on the ESC web-page that may further help to increase the dissemination of contents and visibility of NSCJs. The National Society Cardiovascular Journals (NSCJs) of the European Society of Cardiology (ESC) are high-quality biomedical journals devoted to publishing original research and educative material on cardiovascular diseases. These journals officially belong to the corresponding ESC National Cardiac Societies. Many of them have achieved major international recognition, are included in most important bibliometric databases, and have made major scientiﬁc impact. Some NSCJs offer full-text English content and are freely available in electronic editions. However, NSCJs are largely heterogeneous and some of them are only published in local languages with a limited visibility. The main goal of biomedical journals is to publish high-quality scientiﬁc information. To achieve this goal, journals should compete for the best research carried out in their ﬁeld, the ‘prestige’ of the journal being the main driver to attract original contributions. In turn, a journal’s prestige is based on credibility, diffusion and scientiﬁc impact. To ensure that the scientiﬁc process is fully respected, journals rely in the ‘peer review’ system. This process not only allows the editors to select the best possible material for publication, but also assures the readers that the quality of the information follows the highest scientiﬁc standards. In fact, the process significantly improves the ﬁnal quality of manuscripts eventually published. Once an article is definitely accepted for publication, the journal should guarantee its expedited publication and widespread diffusion among the scientiﬁc community. The Editors’ Network of the ESC provides a unique platform for devising editorial initiatives aimed to improve the scientiﬁc quality, and facilitate diffusion of the contents of NSCJs. Herein we will discuss the importance of the internet and electronic editions in scientiﬁc publishing. We will also review the growing relevance of open access (OA) strategies. Last but not least, we will propose a new initiative based on a novel electronic tool that may further help to increase the diffusion, dissemination and overall visibility of NSCJs. This tool, located on the ESC website, should foster collaboration among the different NSCJs and also broaden exposure from diverse scientiﬁc sites and ESC ofﬁcial journals. Hopefully, this will help to further expand the scientiﬁc impact of European cardiovascular research. Key words: European Society of Cardiology (ESC), National Society Cardiovascular Journals (NSCJs), scientific contents.Medical Archives 10/2013; 67(5):308-313. DOI:10.5455/medarh.2013.67.308-313
Netherlands heart journal: monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 08/2013; 21(9). DOI:10.1007/s12471-013-0455-2 · 2.26 Impact Factor